ResearcherHeidelberg UniversityActive in the last 2 years
Adrian Theophil Billeter
Matched on ORCID iD 0000-0001-8724-4793; OpenAlex author ID A5025980857. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 31
2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper
Papers 6
- Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer: An International Multicenter … Co-author DOI 10.1097/sla.0000000000006532↗
- Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000006687↗
- Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer: An Internation… Co-author DOI 10.1245/s10434-024-16649-z↗
- Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and Colloid Intraductal Papillary Mucinous N… Co-author DOI 10.1245/s10434-025-17810-y↗
- Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal Papillary Mucinous Neoplasia - A Multicen… Co-author DOI 10.1097/sla.0000000000006538↗
- Comment on: Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2. Co-author DOI 10.1016/j.soard.2022.01.007↗
Closest collaborators
The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lois A. Daamen · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Ingmar Florin Rompen · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Brady A. Campbell · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Izaak Quintus Molenaar · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Joseph R. Habib · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paul C. M. Andel · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Marc G. Besselink · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Ammar A. Javed · 5 shared papers, 2024–2026 · strength 0.97
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Greg D. Sacks · 4 shared papers, 2025–2026 · strength 0.80
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Martin Loos · 4 shared papers, 2024–2026 · strength 0.76
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paper Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. DOI 10.1097/sla.0000000000006687↗
- Benedict Kinny‐Köster · 4 shared papers, 2024–2026 · strength 0.76
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paper Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. DOI 10.1097/sla.0000000000006687↗
- Christopher L. Wolfgang · 4 shared papers, 2024–2025 · strength 0.73
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paper Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. DOI 10.1097/sla.0000000000006687↗
- Markus Wolfgang Büchler · 3 shared papers, 2024–2026 · strength 0.59
- Paper Informing Decision-making for Transected Margin Reresection in Intraductal Papillary Mucinous Neoplasm-derived Pancreat… DOI 10.1097/sla.0000000000006532↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paper Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal P… DOI 10.1097/sla.0000000000006538↗
- Jin Peng He · 3 shared papers, 2024–2025 · strength 0.55
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Paper Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal P… DOI 10.1097/sla.0000000000006538↗
- Kelly J. Lafaro · 3 shared papers, 2024–2025 · strength 0.54
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Neoadjuvant Chemotherapy for Intraductal Papillary Mucinous Neoplasm-derived Pancreatic Cancer. DOI 10.1097/sla.0000000000006687↗
- Paper Total versus Partial Pancreatectomy in Patients with Pancreatic Cancer Arising from Multifocal or Diffuse Intraductal P… DOI 10.1097/sla.0000000000006538↗
- Jing He · 2 shared papers, 2025–2026 · strength 0.41
- Camila Hidalgo Salinas · 2 shared papers, 2025 · strength 0.39
- Paper Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-D… DOI 10.1245/s10434-024-16649-z↗
- Paper Incidence and Outcomes of Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Compared with Tubular and … DOI 10.1245/s10434-025-17810-y↗
- Daniel Brock Hewitt · 2 shared papers, 2025 · strength 0.36
- Jörg Kaiser · 2 shared papers, 2025 · strength 0.36
- Hjalmar C. van Santvoort · 1 shared paper, 2026 · strength 0.24
- Christopher Lee Wolfgang · 1 shared paper, 2026 · strength 0.24
- Anthony M Sorrentino · 1 shared paper, 2025 · strength 0.20
- Vincent P. Groot · 1 shared paper, 2025 · strength 0.20
- Zhi Ven Fong · 1 shared paper, 2025 · strength 0.17
- Po Hong Tan · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.